. . . . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . "18"^^ . . . . . . . . "NCT03464136" . "ensayu cl\u00EDnicu"@ast . . . . . . . . . . . . . . . . "klinisch onderzoek"@nl . . . . . . . "Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year"@en . . . . . . . . "A Phase 3b, Multicenter, Randomized, Blinded, Active-Controlled Study to Compare the Efficacy and Safety of Ustekinumab to That of Adalimumab in the Treatment of Biologic Na\u00EFve Subjects With Moderately-to-Severely Active Crohn's Disease"@en . . . . "Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year"@en . . . . "\u056F\u056C\u056B\u0576\u056B\u056F\u0561\u056F\u0561\u0576 \u0583\u0578\u0580\u0571\u0561\u0580\u056F\u0578\u0582\u0574"@hy . . . . . . . . . . . . . . . . "Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year"@en . . . . "SEAVUE"@en . . . . . . . . . . . . . . . . . . "2020-04-30T00:00:00Z"^^ . . . . . . "clinical trial"@en . . . . . . . . . . . . "2018-03-29T00:00:00Z"^^ . "350"^^ . . . . . . . . . . . . . . . .